Algernon Pharmaceuticals (QB) Stock Price

-1.14 (-12.92%)
Volume 9,395
Bid Price 7.10
Ask Price 8.00
News (1)
Day High 9.112


52 Week Range


Day Low 7.50
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Algernon Pharmaceuticals Inc (QB) AGNPF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.14 -12.92% 7.697688 16:11:07
Open Price Low Price High Price Close Price Prev Close
8.95721 7.50 9.112 7.697688 8.84
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
65 9,395 $ 7.8798 $ 74,031 - 0.034 - 9.2795
Last Trade Time Type Quantity Stock Price Currency
15:53:50 30 $ 7.6105 USD


Draw Mode:

Algernon Pharmaceuticals Inc (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.29B 167.49M 151.12M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
25.85k $ - - - -

more financials information »

Algernon Pharmaceuticals (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AGNPF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.139.27955.137.329,0592.5750.05%
1 Month3.209.27953.005.106,5324.50140.55%
3 Months0.06349.27950.0340.0938769288,2917.6312,041.46%
6 Months0.0719.27950.0340.0812022230,7447.6310,741.81%
1 Year0.1929.27950.0340.1710075461,4847.513,909.21%
3 Years0.049.27950.0340.2169497601,5807.6619,144.22%
5 Years0.049.27950.0340.2169497601,5807.6619,144.22%

Algernon Pharmaceuticals (QB) Description

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing.

Your Recent History
Algernon P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.